Welcome to Labeled Immunoassays and Clinical Medicine website!

Screening Test of Hepatitis C Antibody by Chemiluminescent Assay and Enzyme Immunoassay

Expand
  • Department of Laboratory medicine, General Hospital of Jinan Military Area, Jinan 250031, China

Received date: 2012-12-14

  Revised date: 2013-04-16

  Online published: 2013-10-14

Abstract

Objective To compare the detection rate of Anti-hepatitis C virus (anti-HCV) with chemilumines- cence immunoassay (CLIA) and enzyme immunoassay (EIA),and explore the clinical significance of CLIA in diagnosis of HCV infection. Methods The anti- HCV in 6461 patient samples were detected by CLIA and EIA respectively,and anti - HCV positive samples were confirmed with HCV- RNA test. Results The positive rate of anti-HCV in 6461 patient samples determined by CLIA and EIA were 3. 17% and 2. 86%,respectively. The positive coincidence ratio of CLIA detection confirmed by HCV RNA assay (97. 1% ) was obviously higher than that of EIA (91. 9% ) . Among EIA detection samples,while S : CO value was more than 5. 0,the positive coincidence ratio confirmed by HCV RNA was 100% . In weak positive samples,the positive coincidence ratio was only 69. 7%. Among CLIA detection samples,while S : CO value was more than 2. 0,the positive coincidence ratio confirmed by HCV RNA was 100% . In weak positive samples,the positive coincidence ratio was 92. 9% . 31 anti- HCV positive samples detected by CLIA were negative detected by EIA. 4 anti - HCV positive samples detected by EIA were negative detected by CLIA. Conclusion CLIA provides higher specificity and positive predictive value than EIA,and reduces false- positive results. It is effective laboratory procedures for early diagnosis and treatment monitor of hepatitis C vims infection with CLIA.

Cite this article

WANG Yan,YIN Qiu-xia,DOU Heng-li . Screening Test of Hepatitis C Antibody by Chemiluminescent Assay and Enzyme Immunoassay[J]. Labeled Immunoassays and Clinical Medicine, 2013 , 20(4) : 246 -250 . DOI: 10.11748/bjmy. issn. 1006 -1703.2013.04.016

Outlines

/